Endo USA Inc. clinical trials
A subsidiary of Keenova Therapeutics plc
The registry lists 8 studies whose lead sponsor is Endo USA Inc.. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 14, 2026.
Registry sponsor names on this page
- Endo USA Inc., a Keenova Therapeutics Company8 studies
Something wrong with this grouping? Tell us on the Keenova Therapeutics plc page.
Studies
Recruiting first, then most recently updated. Showing 8 of 8. All Keenova Therapeutics plc studies →
- Study to Assess the Long-term Safety of KN3835 in the Treatment and Retreatment of Flexible/Semi-Flexible Hammertoe (HMT)Not yet recruitingNCT07846280Phase 3
Sponsor listed in the registry: Endo USA Inc., a Keenova Therapeutics Company
- Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT)RecruitingNCT07759362Phase 3
Sponsor listed in the registry: Endo USA Inc., a Keenova Therapeutics Company
- Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)CompletedNCT06151197Phase 3
Sponsor listed in the registry: Endo USA Inc., a Keenova Therapeutics Company
- Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar FibromatosisCompletedNCT05152173Phase 2
Sponsor listed in the registry: Endo USA Inc., a Keenova Therapeutics Company
- A Study to Assess Collagenase Clostridium Histolyticum (CCH) in the Treatment of Plantar Fasciitis (PFA)CompletedNCT06169319Phase 2
Sponsor listed in the registry: Endo USA Inc., a Keenova Therapeutics Company
- Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal MenCompletedNCT00467870Phase 3
Sponsor listed in the registry: Endo USA Inc., a Keenova Therapeutics Company
- Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane ImplantCompletedNCT01774435Phase 1
Sponsor listed in the registry: Endo USA Inc., a Keenova Therapeutics Company
- Post-operative Efficacy and Safety StudyCompletedNCT00904085Phase 3
Sponsor listed in the registry: Endo USA Inc., a Keenova Therapeutics Company